【EirGenix】February 2026 Revenue: NT$85M (YoY +100.6%)
NQ Score
60/100
N1 Content Completeness
3
AI Summary (NQ-processed)
EirGenix, Inc. has released its financial report for February 2026, posting a monthly revenue of NT$85 million, which represents a 100.6% growth compared to the same period last year. This figure indicates the biotechnology and medical care company's strong expansion in its CDMO business.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What was EirGenix's revenue for February 2026?
- A: EirGenix reported a monthly revenue of 84,957 thousand NTD for February 2026.
- Q: How did EirGenix's February 2026 revenue compare to the previous year?
- A: EirGenix's revenue in February 2026 showed a significant year-over-year increase of 100.6%.
- Q: What is the company code for EirGenix, Inc.?
- A: The company code assigned to EirGenix, Inc. is 6589.
- Q: In which industry sector does EirGenix, Inc. operate?
- A: EirGenix, Inc. is a company operating within the Biotechnology and Medical Care industry.
- Q: What was the approximate revenue of EirGenix in February 2026 in hundred million NTD?
- A: EirGenix's monthly revenue for February 2026 was approximately 0.85 hundred million NTD.